In addition, IL-1β, IFN-γ, and D-dimer emerged as independent predictors of gastrointestinal complications, reinforcing the critical role of systemic inflammation in developing these adverse effects, particularly in patients with HIV and type II diabetes. Here, IFNG is linked to type 2 diabetes mellitus.